topics / cardiovascular
Tagged cardiovascular.
- Strong human Liraglutide (Victoza / Saxenda): An Evidence Review A once-daily GLP-1 drug with large RCT support for glucose control, weight loss, and lower cardiovascular risk in high-risk type 2 diabetes.
- Strong human Semaglutide (Ozempic / Wegovy): An Evidence Review A GLP-1 drug with strong RCT evidence for weight loss, glucose control, and cutting cardiovascular events in high-risk patients.